Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine

Abstract

Although the course of post-vaccinal meningitis is more benign than that of other forms of the disease, its treatment generates costs related to ancillary exams and hospitalizations. Mass vaccination campaigns should employ less reactogenic vaccine strains.